123 related articles for article (PubMed ID: 24935600)
21. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
22. IL-10 and PRKDC polymorphisms are associated with glioma patient survival.
Hu M; Du J; Cui L; Huang T; Guo X; Zhao Y; Ma X; Jin T; Li G; Song J
Oncotarget; 2016 Dec; 7(49):80680-80687. PubMed ID: 27811370
[TBL] [Abstract][Full Text] [Related]
23. High expression of forkhead box protein C2 is related to poor prognosis in human gliomas.
Wang YW; Yin CL; Zhang HY; Hao J; Yang YY; Liao H; Jiao BH
Asian Pac J Cancer Prev; 2014; 15(24):10621-5. PubMed ID: 25605149
[TBL] [Abstract][Full Text] [Related]
24. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
25. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
He S; Deng J; Li G; Wang B; Cao Y; Tu Y
Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of TELO2 decreases survival in human high-grade gliomas.
Feng SW; Chen Y; Tsai WC; Chiou HC; Wu ST; Huang LC; Lin C; Hsieh CC; Yang YJ; Hueng DY
Oncotarget; 2016 Jul; 7(29):46056-46066. PubMed ID: 27329594
[TBL] [Abstract][Full Text] [Related]
28. Human leukocyte antigen-G overexpression predicts poor clinical outcomes in low-grade gliomas.
Fan X; Wang Y; Zhang C; Liu X; Qian Z; Jiang T
J Neuroimmunol; 2016 May; 294():27-31. PubMed ID: 27138095
[TBL] [Abstract][Full Text] [Related]
29. Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival.
Jing SY; Lu YY; Yang JK; Deng WY; Zhou Q; Jiao BH
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3992-3996. PubMed ID: 27775801
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density.
Cai H; Xue Y; Liu W; Li Z; Hu Y; Li Z; Shang X; Liu Y
J Neurooncol; 2015 May; 123(1):161-9. PubMed ID: 25859844
[TBL] [Abstract][Full Text] [Related]
31. Decreased expression of microRNA-107 predicts poorer prognosis in glioma.
Ji Y; Wei Y; Wang J; Ao Q; Gong K; Zuo H
Tumour Biol; 2015 Jun; 36(6):4461-6. PubMed ID: 25596705
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
Chen W; Yu Q; Chen B; Lu X; Li Q
Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
[TBL] [Abstract][Full Text] [Related]
33. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
[TBL] [Abstract][Full Text] [Related]
34. Low expression of insulin-like growth factor binding protein 7 associated with poor prognosis in human glioma.
Tian X; Zhang L; Sun L; Xue Y; Xie S
J Int Med Res; 2014 Jun; 42(3):651-8. PubMed ID: 24743871
[TBL] [Abstract][Full Text] [Related]
35. Cytoplasmic expression of BAP1 as an independent prognostic biomarker for patients with gliomas.
Zhang XK; Xi SY; Sai K; Chen HD; Zhong ZH; Wu QL; Zeng J
Int J Clin Exp Pathol; 2015; 8(5):5035-43. PubMed ID: 26191197
[TBL] [Abstract][Full Text] [Related]
36. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
Leeper HE; Caron AA; Decker PA; Jenkins RB; Lachance DH; Giannini C
Oncotarget; 2015 Oct; 6(30):30295-305. PubMed ID: 26210286
[TBL] [Abstract][Full Text] [Related]
37. miR-182 as a prognostic marker for glioma progression and patient survival.
Jiang L; Mao P; Song L; Wu J; Huang J; Lin C; Yuan J; Qu L; Cheng SY; Li J
Am J Pathol; 2010 Jul; 177(1):29-38. PubMed ID: 20472885
[TBL] [Abstract][Full Text] [Related]
38. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
Li B; Wang Y; Li S; He H; Sun F; Wang C; Lu Y; Wang X; Tao B
Int J Clin Exp Pathol; 2015; 8(6):7016-21. PubMed ID: 26261592
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
Zhang J; Lv J; Zhang F; Che H; Liao Q; Huang W; Li S; Li Y
J Neurooncol; 2017 Jul; 133(3):553-559. PubMed ID: 28551850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]